Q4 2020 13F Holders as of 12/31/2020
-
Type / Class
-
Equity / Class B Common Stock
-
Shares outstanding
-
5.07M
-
Number of holders
-
477
-
Total 13F shares, excl. options
-
19.6M
-
Shares change
-
+447K
-
Total reported value, excl. options
-
$11.4B
-
Value change
-
+$294M
-
Put/Call ratio
-
1.17
-
Number of buys
-
231
-
Number of sells
-
-223
-
Price
-
$582.94
Significant Holders of BIO-RAD LABORATORIES, INC. - Class B Common Stock (BIO) as of Q4 2020
548 filings reported holding BIO - BIO-RAD LABORATORIES, INC. - Class B Common Stock as of Q4 2020.
BIO-RAD LABORATORIES, INC. - Class B Common Stock (BIO) has 477 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 19.6M shares
.
Largest 10 shareholders include VANGUARD GROUP INC (2.27M shares), BlackRock Inc. (1.89M shares), FMR LLC (1.69M shares), STATE STREET CORP (978K shares), Invesco Ltd. (560K shares), UBS ASSET MANAGEMENT AMERICAS INC (504K shares), BROWN ADVISORY INC (476K shares), WESTFIELD CAPITAL MANAGEMENT CO LP (412K shares), AMERICAN CENTURY COMPANIES INC (406K shares), and ALLIANCEBERNSTEIN L.P. (387K shares).
This table shows the top 477 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.